Avadel Pharmaceuticals (AVDL) News Today $8.00 +0.39 (+5.12%) Closing price 04:00 PM EasternExtended Trading$8.01 +0.01 (+0.06%) As of 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period HC Wainwright Has Negative Estimate for AVDL Q2 EarningsAvadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - HC Wainwright cut their Q2 2025 earnings per share (EPS) estimates for Avadel Pharmaceuticals in a research note issued to investors on Tuesday, March 4th. HC Wainwright analyst O. Livnat now expects that the company will earn ($0.06) per sMarch 8 at 7:18 AM | marketbeat.comHC Wainwright Analysts Decrease Earnings Estimates for AVDLMarch 8 at 2:51 AM | americanbankingnews.comQ3 Earnings Forecast for AVDL Issued By HC WainwrightAvadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - Equities researchers at HC Wainwright issued their Q3 2025 earnings per share estimates for Avadel Pharmaceuticals in a research report issued on Tuesday, March 4th. HC Wainwright analyst O. Livnat forecasts that the company will earn $0.01March 7, 2025 | marketbeat.comWhat is Lifesci Capital's Estimate for AVDL Q2 Earnings?Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - Investment analysts at Lifesci Capital issued their Q2 2025 earnings per share (EPS) estimates for shares of Avadel Pharmaceuticals in a report issued on Monday, March 3rd. Lifesci Capital analyst M. Belghiti expects that the company will pMarch 7, 2025 | marketbeat.comResearch Analysts Set Expectations for AVDL Q1 EarningsMarch 7, 2025 | americanbankingnews.comQ1 Earnings Forecast for AVDL Issued By Lifesci CapitalAvadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - Stock analysts at Lifesci Capital issued their Q1 2025 earnings per share (EPS) estimates for shares of Avadel Pharmaceuticals in a report issued on Monday, March 3rd. Lifesci Capital analyst M. Belghiti forecasts that the company will earnMarch 6, 2025 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Avadel Pharmaceuticals (NASDAQ:AVDL)March 6, 2025 | americanbankingnews.comOppenheimer & Co. Inc. Purchases 33,963 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)Oppenheimer & Co. Inc. boosted its position in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 102.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 67,068 shares of the company's stock afterMarch 6, 2025 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Up - Time to Buy?Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Up - Here's What HappenedMarch 5, 2025 | marketbeat.comAvadel Pharmaceuticals to Present at Upcoming Investor ConferencesMarch 5, 2025 | globenewswire.comNew York State Common Retirement Fund Sells 389,555 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)New York State Common Retirement Fund cut its stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 92.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 31,200 shares of the company's stock after selling 389,555 sharMarch 5, 2025 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Receives "Buy" Rating from Needham & Company LLCMarch 5, 2025 | americanbankingnews.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2024 Earnings Call TranscriptMarch 4, 2025 | msn.comAvadel Pharmaceuticals (NASDAQ:AVDL) Receives Buy Rating from HC WainwrightHC Wainwright reissued a "buy" rating and set a $21.00 price objective on shares of Avadel Pharmaceuticals in a research report on Tuesday.March 4, 2025 | marketbeat.comAvadel Pharmaceuticals plc (AVDL) Q4 2024 Earnings Call TranscriptMarch 4, 2025 | seekingalpha.comAvadel Pharmaceuticals plc 2024 Q4 - Results - Earnings Call PresentationMarch 3, 2025 | seekingalpha.comAvadel Pharmaceuticals sees FY25 net product revenue $240M-$260MMarch 3, 2025 | markets.businessinsider.comCraig-Hallum Sticks to Its Buy Rating for Avadel Pharmaceuticals (AVDL)March 3, 2025 | markets.businessinsider.comAvadel: Q4 Earnings SnapshotMarch 3, 2025 | sfgate.comAvadel Pharmaceuticals' (AVDL) "Buy" Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC restated a "buy" rating and set a $19.00 price target on shares of Avadel Pharmaceuticals in a research note on Monday.March 3, 2025 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPSAvadel Pharmaceuticals (NASDAQ:AVDL - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.02). Avadel Pharmaceuticals had a negative return on equity of 93.34% and a negative net margin of 52.53%.March 3, 2025 | marketbeat.comAvadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 3, 2025 | globenewswire.comModera Wealth Management LLC Increases Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Modera Wealth Management LLC increased its holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 29.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 782,567 shares of the company's stock after purchasing an addMarch 3, 2025 | marketbeat.comIs Avadel Pharmaceuticals plc (AVDL) the Best Small Cap Pharma Stocks to Buy Now?March 1, 2025 | msn.comAvadel Pharmaceuticals (AVDL) Expected to Announce Quarterly Earnings on MondayMarch 1, 2025 | americanbankingnews.comAvadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on March 3February 24, 2025 | globenewswire.comAvadel Pharmaceuticals appoints Kevin Springman as VP, salesFebruary 24, 2025 | markets.businessinsider.comAvadel Pharmaceuticals Appoints Kevin Springman as Vice President of SalesFebruary 24, 2025 | globenewswire.comAvadel Pharmaceuticals (AVDL) Projected to Post Quarterly Earnings on MondayAvadel Pharmaceuticals (NASDAQ:AVDL) will be releasing earnings before the market opens on Monday, March 3.February 24, 2025 | marketbeat.comAvadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)February 20, 2025 | globenewswire.com3 Stocks With Robust Growth Outlooks Insiders Are Buying (AVDL)February 19, 2025 | insidertrades.comShort Interest in Avadel Pharmaceuticals plc (NASDAQ:AVDL) Drops By 8.3%Avadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) was the recipient of a significant drop in short interest during the month of January. As of January 31st, there was short interest totalling 10,550,000 shares, a drop of 8.3% from the January 15th total of 11,510,000 shares. Based on an average daily volume of 1,520,000 shares, the short-interest ratio is currently 6.9 days.February 17, 2025 | marketbeat.comAlphaCentric Advisors LLC Invests $354,000 in Avadel Pharmaceuticals plc (NASDAQ:AVDL)AlphaCentric Advisors LLC purchased a new stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 33,650 shares of the company's stock, valued at approximately $354,000. Several other hFebruary 17, 2025 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Receives Average Rating of "Buy" from AnalystsAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) has been assigned an average recommendation of "Buy" from the eight brokerages that are currently covering the company, Marketbeat.com reports. Eight investment analysts have rated the stock with a buy rating. The average 12 month target pFebruary 15, 2025 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Up 7.2% - Still a Buy?Avadel Pharmaceuticals (NASDAQ:AVDL) Trading 7.2% Higher - Here's What HappenedFebruary 12, 2025 | marketbeat.comDeutsche Bank Initiates Coverage of Avadel Pharmaceuticals (AVDL) with Buy RecommendationFebruary 12, 2025 | msn.comAvadel Pharmaceuticals: Moving To A Speculative BuyFebruary 11, 2025 | seekingalpha.comAvadel Pharmaceuticals initiated with a Buy at Deutsche BankFebruary 11, 2025 | markets.businessinsider.comAvadel Pharmaceuticals (NASDAQ:AVDL) Coverage Initiated by Analysts at Deutsche Bank AktiengesellschaftDeutsche Bank Aktiengesellschaft began coverage on Avadel Pharmaceuticals in a report on Tuesday. They set a "buy" rating and a $12.00 price target on the stock.February 11, 2025 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Trading 7.2% Higher - What's Next?Avadel Pharmaceuticals (NASDAQ:AVDL) Stock Price Up 7.2% - Here's What HappenedFebruary 10, 2025 | marketbeat.comSG Americas Securities LLC Raises Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL)SG Americas Securities LLC increased its position in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 274.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 46,767 shares of the company's stock after buying an additional 34,281 shares during the perFebruary 2, 2025 | marketbeat.comLeerink Partnrs Brokers Increase Earnings Estimates for AVDLAvadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - Stock analysts at Leerink Partnrs lifted their FY2027 earnings estimates for Avadel Pharmaceuticals in a research report issued on Wednesday, January 29th. Leerink Partnrs analyst M. Goodman now forecasts that the company will post earningsJanuary 31, 2025 | marketbeat.comWealth Effects LLC Acquires 110,359 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)Wealth Effects LLC grew its stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 4.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 2,344,130 shares of the company's stock after acquiring an additional 110,359 shares during the perioJanuary 28, 2025 | marketbeat.comJPMorgan Chase & Co. Decreases Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL)JPMorgan Chase & Co. reduced its stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 37.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 115,025 shares of the company's stock after selling 68,January 24, 2025 | marketbeat.comLinda Palczuk Acquires 5,000 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) StockJanuary 23, 2025 | insidertrades.comAvadel Pharmaceuticals plc: Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and ReimbursementJanuary 22, 2025 | finanznachrichten.deAvadel Pharmaceuticals director Linda Palczuk acquires $39,640 in sharesJanuary 22, 2025 | msn.comLinda Palczuk Purchases 5,000 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) StockAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) Director Linda Palczuk acquired 5,000 shares of the stock in a transaction dated Tuesday, January 21st. The stock was acquired at an average cost of $7.93 per share, for a total transaction of $39,650.00. Following the purchase, the director now directly owns 67,900 shares in the company, valued at approximately $538,447. The trade was a 7.95 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.January 22, 2025 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Given Average Rating of "Buy" by AnalystsShares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) have received an average rating of "Buy" from the seven analysts that are currently covering the firm, MarketBeat reports. Seven analysts have rated the stock with a buy recommendation. The average 12-month price target among broJanuary 21, 2025 | marketbeat.comThere May Still Be Time to Get in on These 3 Trending BiotechsBiotech firms as a group declined slightly in the last year amid a tough external environment, but these three companies could grow in 2025.January 20, 2025 | marketbeat.com Remove Ads Get Avadel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter. Email Address AVDL Media Mentions By Week AVDL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVDL News Sentiment▼0.700.60▲Average Medical News Sentiment AVDL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVDL Articles This Week▼264▲AVDL Articles Average Week Remove Ads Get Avadel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ACAD News Today MOR News Today BHVN News Today AMRX News Today HCM News Today EWTX News Today XENE News Today BHC News Today MTSR News Today CPRX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVDL) was last updated on 3/11/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avadel Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Avadel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
